Search

Author/Creator Birnbaum, Ariel

1. Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial. Issue 4 (12th April 2022)

Authors:
Aggarwal, Charu; Prawira, Amy; Antonia, Scott; Rahma, Osama; Tolcher, Anthony; Cohen, Roger B; Lou, Yanyan; Hauke, Ralph; Vogelzang, Nicholas; P Zandberg, Dan; Kalebasty, Arash Rezazadeh; Atkinson, Victoria; Adjei, Alex A; Seetharam, Mahesh; Birnbaum, Ariel; Weickhardt, Andrew; Ganju, Vinod; Josh...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. First‐in‐Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. (4th March 2019)

Authors:
He, Aiwu Ruth; Cohen, Roger B.; Denlinger, Crystal S.; Sama, Ashwin; Birnbaum, Ariel; Hwang, Jimmy; Sato, Takami; Lewis, Nancy; Mynderse, Michelle; Niland, Michele; Giles, Jennifer; Wallin, Johan; Moser, Brian; Zhang, Wei; Walgren, Richard; Plimack, Elizabeth R.
Journal:
Oncologist
Issue:
Volume 24:Number 9(2019)
Page Start:
e930
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search